[{"begin": 0, "end": 159, "text": "Reckamp Karen L, Krysan Kostyantyn, Morrow Jason D, Milne Ginger L, Newman Robert A, Tucker Christopher, Elashoff Robert M, Dubinett Steven M, Figlin Robert A,", "tokenized_text": "Reckamp Karen L , Krysan Kostyantyn , Morrow Jason D , Milne Ginger L , Newman Robert A , Tucker Christopher , Elashoff Robert M , Dubinett Steven M , Figlin Robert A ,", "type": "authors", "id": 0}, {"begin": 160, "end": 258, "text": "A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib", "tokenized_text": "A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib", "type": "title", "id": 1}, {"begin": 259, "end": 297, "text": "in advanced non-small cell lung cancer", "tokenized_text": "in advanced non - small cell lung cancer", "type": "title", "id": 2}, {"begin": 299, "end": 393, "text": "Clinical cancer research : an official journal of the American Association for Cancer Research", "tokenized_text": "Clinical cancer research : an official journal of the American Association for Cancer Research", "type": "venue", "id": 3}, {"begin": 395, "end": 399, "text": "2006", "tokenized_text": "2006", "type": "year", "id": 4}]